ATE163131T1 - Bpc-peptide, deren herstellung und therapeutischen verwendung - Google Patents

Bpc-peptide, deren herstellung und therapeutischen verwendung

Info

Publication number
ATE163131T1
ATE163131T1 AT94901809T AT94901809T ATE163131T1 AT E163131 T1 ATE163131 T1 AT E163131T1 AT 94901809 T AT94901809 T AT 94901809T AT 94901809 T AT94901809 T AT 94901809T AT E163131 T1 ATE163131 T1 AT E163131T1
Authority
AT
Austria
Prior art keywords
bpc
production
therapeutic use
peptides
amino acid
Prior art date
Application number
AT94901809T
Other languages
English (en)
Inventor
Marijan Mr Sc Petek
Sven Seiwerth
Predrag Dr Sc Sikiric
Zeljko Grabarevic
Ivo Mr Sc Rotkvic
Marko Duvnjak
Branko Turkovic
Stjepan Mr Sc Mise
Ernest Dr Sc Suchanek
Boris Mildner
Ivan Udovicic
Original Assignee
Petek Marijan
Sven Seiwerth
Sikiric Predrag
Zeljko Grabarevic
Rotkvic Ivo
Marko Duvnjak
Branko Turkovic
Stjepan Mr Sc Mise
Suchanek Ernest
Boris Mildner
Ivan Udovicic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Petek Marijan, Sven Seiwerth, Sikiric Predrag, Zeljko Grabarevic, Rotkvic Ivo, Marko Duvnjak, Branko Turkovic, Stjepan Mr Sc Mise, Suchanek Ernest, Boris Mildner, Ivan Udovicic filed Critical Petek Marijan
Application granted granted Critical
Publication of ATE163131T1 publication Critical patent/ATE163131T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT94901809T 1992-11-16 1993-11-16 Bpc-peptide, deren herstellung und therapeutischen verwendung ATE163131T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HR921283 1992-11-16

Publications (1)

Publication Number Publication Date
ATE163131T1 true ATE163131T1 (de) 1998-02-15

Family

ID=10945833

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94901809T ATE163131T1 (de) 1992-11-16 1993-11-16 Bpc-peptide, deren herstellung und therapeutischen verwendung

Country Status (17)

Country Link
EP (1) EP0624164B1 (de)
JP (1) JP2812803B2 (de)
AT (1) ATE163131T1 (de)
AU (1) AU5624994A (de)
BG (1) BG61697B1 (de)
CA (1) CA2127553C (de)
CZ (1) CZ285155B6 (de)
DE (1) DE69316974T2 (de)
ES (1) ES2114170T3 (de)
GR (1) GR3026478T3 (de)
HU (3) HUT66303A (de)
PL (1) PL304666A1 (de)
RO (1) RO115733B1 (de)
RU (1) RU2116311C1 (de)
SI (1) SI9300595B (de)
SK (1) SK279227B6 (de)
WO (1) WO1994011394A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL132884A0 (en) * 1997-05-23 2001-03-19 Sikiric Predrag Body protection compound peptide salts with organo-protective activity pharmaceutical and diagnostic compositions containing the same the use thereof and process for preparing the same
SI24318A (sl) * 2013-03-13 2014-09-30 Diagen D.O.O. Nove stabilne soli pentadekapeptida, postopek za njihovo pripravo, njihova uporaba za izdelavo farmacevtskih pripravkov in njihova uporaba v terapiji

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU176089A (sh) * 1989-09-12 1992-09-07 Sikirić, Predrag Postupak za pripremu supstancije bpc i supstancija bpc
ATE152734T1 (de) * 1992-05-30 1997-05-15 Sikiric Predrag Bpc-peptide, deren herstellung und verwendung

Also Published As

Publication number Publication date
SK85794A3 (en) 1995-01-12
HUT67982A (en) 1995-05-29
HU9401952D0 (en) 1994-09-28
PL304666A1 (en) 1995-01-09
HU9303247D0 (en) 1994-03-28
GR3026478T3 (en) 1998-06-30
BG61697B1 (bg) 1998-03-31
DE69316974D1 (de) 1998-03-19
CZ285155B6 (cs) 1999-05-12
EP0624164B1 (de) 1998-02-11
BG98907A (bg) 1995-05-31
EP0624164A1 (de) 1994-11-17
JP2812803B2 (ja) 1998-10-22
CA2127553C (en) 2003-01-28
CA2127553A1 (en) 1994-05-26
WO1994011394A3 (en) 1994-09-15
WO1994011394A2 (en) 1994-05-26
SK279227B6 (sk) 1998-08-05
RU2116311C1 (ru) 1998-07-27
DE69316974T2 (de) 1998-07-16
ES2114170T3 (es) 1998-05-16
HU211260A9 (en) 1995-11-28
RO115733B1 (ro) 2000-05-30
CZ162294A3 (en) 1995-02-15
AU5624994A (en) 1994-06-08
SI9300595B (sl) 2003-04-30
SI9300595A (en) 1994-09-30
JPH07507568A (ja) 1995-08-24
HUT66303A (en) 1994-11-28
RU94037232A (ru) 1996-06-20

Similar Documents

Publication Publication Date Title
EP0726706A4 (de) N, n'-disubstituierte guanidine und ihre verwendung als antagonisten exzitatorischer aminosäuren
NZ210194A (en) Pentapeptides with thymopoietin and splenin like activity
DE69731373D1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
BG91270A (bg) Антивирусно и антибактериално средство и метод за използването му
DE69219590D1 (de) BPC-Peptide, deren Herstellung und Verwendung
ATE256182T1 (de) Neuartiges p- selectin ligandenprotein
RU94041224A (ru) Пептиды с органозащитной активностью, фармацевтическая композиция на их основе и их применение в терапии
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
ES2058479T3 (es) Compuestos peptidicos.
ATE163131T1 (de) Bpc-peptide, deren herstellung und therapeutischen verwendung
ATE310083T1 (de) Deprenyl induziertes protein

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification